Arteris, Inc. (NASDAQ:AIP – Get Free Report) Director Wayne C. Cantwell sold 5,000 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $11.01, for a total transaction of $55,050.00. Following the transaction, the director now owns 233,198 shares in the company, valued at $2,567,509.98. The trade was a 2.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Arteris Stock Performance
NASDAQ AIP opened at $11.25 on Thursday. The stock has a market cap of $451.99 million, a PE ratio of -11.72 and a beta of 1.17. Arteris, Inc. has a 12 month low of $4.83 and a 12 month high of $12.64. The company’s 50-day moving average price is $9.08 and its 200-day moving average price is $8.11. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30.
Analysts Set New Price Targets
Separately, Rosenblatt Securities reaffirmed a “buy” rating and set a $15.00 target price on shares of Arteris in a research note on Wednesday, November 6th.
Hedge Funds Weigh In On Arteris
A number of institutional investors have recently modified their holdings of AIP. US Bancorp DE purchased a new stake in shares of Arteris in the third quarter valued at approximately $34,000. The Manufacturers Life Insurance Company purchased a new position in Arteris during the 2nd quarter worth $86,000. Algert Global LLC bought a new stake in Arteris during the 2nd quarter valued at $115,000. MetLife Investment Management LLC lifted its holdings in shares of Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after buying an additional 9,551 shares during the period. Finally, Dynamic Technology Lab Private Ltd bought a new position in shares of Arteris during the 3rd quarter worth $226,000. 64.36% of the stock is owned by hedge funds and other institutional investors.
About Arteris
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Recommended Stories
- Five stocks we like better than Arteris
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Manufacturing Stocks Investing
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- What to Know About Investing in Penny Stocks
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.